Pharmascience Inc. v. Janssen Inc.
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Federal Court (Canada) |
| Citation | 2024 FC 440 |
| Date | 19 March 2024 |
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeUnlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Start Your 7-day Trial
2 practice notes
-
Farah v. Canada (Foreign Affairs)
...a result, this Court will not intervene lightly in a discretionary decision of a case management judge: Pharmascience Inc v Janssen Inc, 2024 FC 440 at para 10, citing Hutton v Sayat, 2020 FC 1183 at para 28; Mobile Telesystems Public Joint Stock Company v Canada (Attorney General), 2025 FC......
-
Canadian Patent Law: 2024 In Review
...motion was denied, with the settlement agreements being protected by settlement privilege. The second motion, Pharmascience v Janssen (2024 FC 440), was an appeal of an interlocutory order requiring the plaintiff in a section 8 proceeding to produce its financial statements. The appeal was ......
1 cases
-
Farah v. Canada (Foreign Affairs)
...a result, this Court will not intervene lightly in a discretionary decision of a case management judge: Pharmascience Inc v Janssen Inc, 2024 FC 440 at para 10, citing Hutton v Sayat, 2020 FC 1183 at para 28; Mobile Telesystems Public Joint Stock Company v Canada (Attorney General), 2025 FC......
1 firm's commentaries
-
Canadian Patent Law: 2024 In Review
...motion was denied, with the settlement agreements being protected by settlement privilege. The second motion, Pharmascience v Janssen (2024 FC 440), was an appeal of an interlocutory order requiring the plaintiff in a section 8 proceeding to produce its financial statements. The appeal was ......